Search research articles
Contact Us
Filters
Showing results (101-110 of 107) with videos related to
Page
of 11
Sort By:
You have reached the last page of results.
This site can display upto 107 results.
British Journal of Cancer
|
August 14, 2003
Summary of the Standards, Options and Recommendations for the use of positron emission tomography with 2-[18F]fluoro-2-deoxy-D-glucose (FDP-PET scanning) in oncology (2002)
P Bourguet, M P Blanc-Vincent, A Boneu, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|
February 15, 2011
[Locally advanced unresectable pancreatic cancer: Induction chemoradiotherapy followed by maintenance gemcitabine versus gemcitabine alone: Definitive results of the 2000-2001 FFCD/SFRO phase III trial]
M Barhoumi, F Mornex, F Bonnetain, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
September 25, 2020
Phase 1 trial of ralimetinib (LY2228820) with radiotherapy plus concomitant temozolomide in the treatment of newly diagnosed glioblastoma
J Biau, E Thivat, E Chautard, et al.
Alimentary Pharmacology & Therapeutics
|
April 18, 2014
Idarubicin-loaded beads for chemoembolisation of hepatocellular carcinoma: results of the IDASPHERE phase I trial
M Boulin, P Hillon, J P Cercueil, et al.
British Journal of Cancer
|
December 17, 2011
Intraperitoneal clearance as a potential biomarker of cisplatin after intraperitoneal perioperative chemotherapy: a population pharmacokinetic study
B Royer, E Kalbacher, S Onteniente, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 12, 2014
Randomized phase II trial of irinotecan and bevacizumab as neo-adjuvant and adjuvant to temozolomide-based chemoradiation compared with temozolomide-chemoradiation for unresectable glioblastoma: final results of the TEMAVIR study from ANOCEF†
B Chauffert, L Feuvret, F Bonnetain, et al.
Revue Neurologique
|
June 21, 2008
[Bevacizumab/irinotecan. An active treatment for recurrent high grade gliomas: preliminary results of an ANOCEF Multicenter Study]
S Guiu, S Taillibert, O Chinot, et al.
Page
of 11
Search research articles
Search
Showing results (101-110 of 107) with videos related to
Sort By:
Page
of 11
You have reached the last page of results.
This site can display upto 107 results.
British Journal of Cancer
|
August 14, 2003
Summary of the Standards, Options and Recommendations for the use of positron emission tomography with 2-[18F]fluoro-2-deoxy-D-glucose (FDP-PET scanning) in oncology (2002)
P Bourguet, M P Blanc-Vincent, A Boneu, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|
February 15, 2011
[Locally advanced unresectable pancreatic cancer: Induction chemoradiotherapy followed by maintenance gemcitabine versus gemcitabine alone: Definitive results of the 2000-2001 FFCD/SFRO phase III trial]
M Barhoumi, F Mornex, F Bonnetain, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
September 25, 2020
Phase 1 trial of ralimetinib (LY2228820) with radiotherapy plus concomitant temozolomide in the treatment of newly diagnosed glioblastoma
J Biau, E Thivat, E Chautard, et al.
Alimentary Pharmacology & Therapeutics
|
April 18, 2014
Idarubicin-loaded beads for chemoembolisation of hepatocellular carcinoma: results of the IDASPHERE phase I trial
M Boulin, P Hillon, J P Cercueil, et al.
British Journal of Cancer
|
December 17, 2011
Intraperitoneal clearance as a potential biomarker of cisplatin after intraperitoneal perioperative chemotherapy: a population pharmacokinetic study
B Royer, E Kalbacher, S Onteniente, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 12, 2014
Randomized phase II trial of irinotecan and bevacizumab as neo-adjuvant and adjuvant to temozolomide-based chemoradiation compared with temozolomide-chemoradiation for unresectable glioblastoma: final results of the TEMAVIR study from ANOCEF†
B Chauffert, L Feuvret, F Bonnetain, et al.
Revue Neurologique
|
June 21, 2008
[Bevacizumab/irinotecan. An active treatment for recurrent high grade gliomas: preliminary results of an ANOCEF Multicenter Study]
S Guiu, S Taillibert, O Chinot, et al.
Page
of 11